NET PROFIT (x1000 DKK)
EMPLOYEES
Lokon Pharma AB
Closing information (x1000 DKK)
| Closing information | 2022/12 | 2021/12 | 2020/12 |
| Turnover |
0
|
0
|
0 |
| Financial expenses |
1
|
0
|
1 |
| Earnings before taxes |
-48,500
|
-49,409
|
-33,675 |
| EBITDA |
-48,488
|
-49,396
|
-33,661 |
| Total assets |
9,857
|
10,264
|
10,374 |
| Current assets |
9,833
|
10,225
|
10,321 |
| Current liabilities |
9,484
|
9,655
|
9,789 |
| Equity capital |
373
|
609
|
585 |
| - share capital |
33
|
36
|
37 |
| Employees (average) |
8
|
7
|
7 |
Financial ratios
| Fiscal year | 2022/12 | 2021/12 | 2020/12 |
| Solvency |
3.8%
|
5.9%
|
5.6% |
| Turnover per employee |
0
|
0
|
0 |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) |
-492.0%
|
-481.4%
|
-324.6% |
| Current ratio |
103.7%
|
105.9%
|
105.4% |
| Return on equity (ROE) |
-13002.7%
|
-8113.1%
|
-5756.4% |
| Change turnover |
0
|
0
|
-225 |
| Change turnover % | -100% | ||
| Chg. No. of employees |
1
|
0
|
4 |
| Chg. No. of employees % |
14%
|
0%
|
133% |
Total value of public sale
| Fiscal year | 2022/12 | 2021/12 | 2020/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.